Prevention of de novo hepatitis B with adefovir plus vaccination in recipients of liver transplants from core antibody-positive donors.

TitlePrevention of de novo hepatitis B with adefovir plus vaccination in recipients of liver transplants from core antibody-positive donors.
Publication TypeJournal Article
Year of Publication2013
AuthorsChang MS, Olsen SK, Pichardo EM, Heese S, Stiles JB, Guarrera JV, Emond JC, Brown, Jr RS
JournalLiver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society//Liver Transpl
Volume19
Issue4
Pagination462
Date Published2013
ISBN Number1527-6473
Other Numbersdk0, 100909185
Keywords*Adenine/aa [Analogs & Derivatives], *Antiviral Agents/tu [Therapeutic Use], *Hepatitis B Core Antigens/bl [Blood], *Hepatitis B Vaccines/tu [Therapeutic Use], *Hepatitis B virus/de [Drug Effects], *Hepatitis B/pc [Prevention & Control], *Liver Transplantation/ae [Adverse Effects], *Organophosphonates/tu [Therapeutic Use], *Tissue Donors, Adenine/ae [Adverse Effects], Adenine/tu [Therapeutic Use], Adult, Aged, Antiviral Agents/ae [Adverse Effects], Biological Markers/bl [Blood], Deoxycytidine/aa [Analogs & Derivatives], Deoxycytidine/tu [Therapeutic Use], DNA, Viral/bl [Blood], Drug Substitution, Guanine/aa [Analogs & Derivatives], Guanine/tu [Therapeutic Use], Hepatitis B Antibodies/bl [Blood], Hepatitis B virus/ge [Genetics], Hepatitis B virus/im [Immunology], Hepatitis B/bl [Blood], Hepatitis B/di [Diagnosis], Hepatitis B/tm [Transmission], Humans, Middle Aged, Organophosphonates/ae [Adverse Effects], Time Factors, Treatment Outcome
Notify Library Reference ID4050

Related Incidents